These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25517806)

  • 61. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling.
    Kanazawa H
    Curr Opin Pulm Med; 2006 Jan; 12(1):60-7. PubMed ID: 16357581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents.
    Rodrigo GJ; Neffen H
    Pediatr Allergy Immunol; 2015 Sep; 26(6):551-6. PubMed ID: 25963882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
    Price D; Fromer L; Kaplan A; van der Molen T; Román-Rodríguez M
    NPJ Prim Care Respir Med; 2014 Jul; 24():14023. PubMed ID: 25030457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy and safety of reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: A systematic review and meta-analysis.
    Li J; Wang F; Lin C; Du J; Xiao B; Du C; Sun J
    J Asthma; 2017 Apr; 54(3):300-307. PubMed ID: 27435534
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emerging role of long-acting anticholinergics in children with asthma.
    Vogelberg C
    Curr Opin Pulm Med; 2016 Jan; 22(1):74-9. PubMed ID: 26606079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Meta-analysis of randomized controlled trials for the efficacy and safety of anti-interleukin-13 therapy with lebrikizumab in patients with uncontrolled asthma.
    Liu Y; Zhang S; Chen R; Wei J; Guan G; Zhou M; Dong N; Cao Y
    Allergy Asthma Proc; 2018 Sep; 39(5):332-337. PubMed ID: 30153886
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Xiong XF; Zhu M; Wu HX; Fan LL; Cheng DY
    Respir Res; 2019 May; 20(1):108. PubMed ID: 31151443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data.
    Hong SH; Cho JY; Kim TB; Lee EK; Kwon SH; Shin JY
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1939-1947.e7. PubMed ID: 33307277
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Austrian Society of Lung Diseases and Tuberculosis: consensus on diagnosis and therapy of bronchial asthma in adults].
    Aigner K; Forche G; Kneussl M; Pohl W; Schlick W;
    Wien Klin Wochenschr; 2004 May; 116(9-10):339-45. PubMed ID: 15237662
    [No Abstract]   [Full Text] [Related]  

  • 70. Anticholinergic drugs in asthma therapy.
    D'Amato M; Vitale C; Molino A; Lanza M; D'Amato G
    Curr Opin Pulm Med; 2017 Jan; 23(1):103-108. PubMed ID: 27820743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials.
    Zayed Y; Kheiri B; Banifadel M; Hicks M; Aburahma A; Hamid K; Bachuwa G; Chandran A
    J Asthma; 2019 Oct; 56(10):1110-1119. PubMed ID: 30273510
    [No Abstract]   [Full Text] [Related]  

  • 72. Commentary on "Tiotropium in the treatment of patients with asthma".
    Burki NK
    South Med J; 2014 May; 107(5):338-9. PubMed ID: 24937737
    [No Abstract]   [Full Text] [Related]  

  • 73. Key observations from the NHLBI Asthma Clinical Research Network.
    Szefler SJ; Chinchilli VM; Israel E; Denlinger LC; Lemanske RF; Calhoun W; Peters SP;
    Thorax; 2012 May; 67(5):450-5. PubMed ID: 22514237
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tiotropium for asthma--promise and caution.
    Bel EH
    N Engl J Med; 2012 Sep; 367(13):1257-9. PubMed ID: 22938707
    [No Abstract]   [Full Text] [Related]  

  • 75. Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?
    Liccardi G; Calzetta L; Salzillo A; Piccolo A; Pane G; Rogliani P
    Expert Opin Pharmacother; 2017 Jun; 18(8):833-835. PubMed ID: 28399659
    [No Abstract]   [Full Text] [Related]  

  • 76. Reply to 'Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?'.
    Hamelmann E; Vogelberg C; Szefler SJ
    Expert Opin Pharmacother; 2017 Jun; 18(8):837-838. PubMed ID: 28399660
    [No Abstract]   [Full Text] [Related]  

  • 77. The efficacy of tiotropium as a steroid-sparing agent in severe asthma.
    Kapoor AS; Olsen SR; O'Hara C; Puttagunta L; Vethanayagam D
    Can Respir J; 2009; 16(3):99-101. PubMed ID: 19557217
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tiotropium bromide triple combination therapy improves lung function and decreases asthma exacerbations.
    Peters SP
    Evid Based Med; 2013 Oct; 18(5):179. PubMed ID: 23349214
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy and Safety of Prostaglandin D2 Receptor 2 Antagonism with Fevipiprant for Patients with Asthma: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Yang D; Guo X; Liu T; Li Y; Du Z; Liu C
    Curr Allergy Asthma Rep; 2021 Aug; 21(7):39. PubMed ID: 34387775
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anticholinergic Bronchodilator Therapy of Asthma-Ageless.
    Chapman KR
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2661-2662. PubMed ID: 32888532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.